a Home
a About the Lab
a Group Statistics
a About Tony Kouzarides
a Research Interests
a Publications
a Current group members
a Past group members
a Find Us
a Lab Retreats
a Lab Events
a Links
a University of Cambridge
a School of Biological Sciences
a The Gurdon Institute
a Cancer Research UK
a Hermes Webmail
a Pubmed
a BBC News
a Google


Biography: Prof. Tony Kouzarides PhD, FMedSci, FRS

Tony Kouzarides is Professor of Cancer Biology at the University of Cambridge, Deputy Director of the Gurdon Institute and Director of the Milner Therapeutics Institute.

Tony did his PhD at the University of Cambridge and postdoctoral work at MRC Laboratory of Molecular Biology on the cancer inducing potential of human cytomegalovirus. He then went to NYU Medical Center in New York where he worked on the c-Fos onco-protein and the characterization of the leucine zipper. He returned to Cambridge to lead a research group at the Gurdon Institute.

Tony's research group at the Gurdon Institute is focused on epigenetic modifications on Chromatin, RNA and DNA and their involvement in cancer. His laboratory identified one of the first enzymes that modify chromatin, the acetyltransferase CBP. The Kouzarides lab has also discovered many other chromatin modification pathways including deimination, proline isomerisation and tyrosine phoshorylation and glutamine methylation. His group identified HP1 as a protein that binds to methyl-lysine 9 on Histone H3. Many links between epigenetic modifications and cancer have been demonstrated by his group. Most recently a small molecule inhibitor I-BET has been shown to be effective against epigenetic pathways leading to MLL-leukaemia. This I-BET compound is currently in clinical trials.

Tony is part of the Executive Board of the Cambridge Cancer Centre and on the Scientific Advisory Board of two Institutes on Spain (CRG in Barcelona and CABIMER in Seville). He is the founder and director of a cancer charity based in Spain called "Vencer el Cancer" (Conquer Cancer), which raises public funds from the Spanish public to fund research on cancer. 

Tony is a co- founder of Abcam plc, (a publicly trading research reagents company) a co-founder of two UK based cancer drug discovery companies, Chroma Therapeutics (based in Oxford) and STORM Therapeutics (based in Cambridge).

Tony has been elected member of the European Molecular Biology organization, is a Fellow of the British Academy of Medical Sciences (FMedSci), Fellow of the Royal Society (FRS) and is a Cancer Research UK Gibbs Fellow. He has been awarded the Wellcome Trust medal for research in biochemistry related to medicine (UK), the Tenovus Medal (UK), the Bodossaki Foundation prize in Biology (Greece), the Bijvoet Medal (Holland), the Biochemical Society Award Novartis Medal and Prize (UK) and the Heinrich Wieland Prize (Germany).


Entire Publication List


Website created by Trent Munro in 2004. Maintained by Nikki Mann (Last update: Feb 2016)